Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Multiple Myeloma 81Neoplasms, Plasma Cell 27Neoplasms 13Brain Neoplasms 11Prostatic Neoplasms 10Central Nervous System Neoplasms 10Melanoma 9Leukemia 9Glioblastoma 8Gliosarcoma 7Glioma 7Leukemia, Lymphocytic, Chronic, B-Cell 6Carcinoma, Hepatocellular 6Recurrence 5Myeloproliferative Disorders 5Myelodysplastic Syndromes 5Lymphoma, Mantle-Cell 5Lung Neoplasms 5Waldenstrom Macroglobulinemia 4Sarcoma 4Myelodysplastic-Myeloproliferative Diseases 4Lymphoma, B-Cell, Marginal Zone 4Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 4Immunoglobulin Light-chain Amyloidosis 4Carcinoma, Renal Cell 4Uveal Melanoma 3Oligodendroglioma 3Neuroblastoma 3Lymphoma, Non-Hodgkin 3Lymphoma, Follicular 3

Interventions

Irinotecan 6Cyclophosphamide 3temsirolimus 2Sirolimus 2Early Intervention, Educational 2reolysin 1irofulven 1cixutumumab 1aflibercept 1Vincristine 1Trabectedin 1Tirapazamine 1Thalidomide 1Temozolomide 1Pemetrexed 1Oxaliplatin 1Immunohistochemistry 1Gemcitabine 1Gefitinib 1Filgrastim 1Enzyme-Linked Immunosorbent Assay 1Counseling 1Cisplatin 1Carboplatin 1Bortezomib 1Bevacizumab 1Amifostine 1Absorptiometry, Photon 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Unspecified Childhood Solid Tumor, Protocol Specific × Thalidomide × Clear all
NCT00003754 2013-06-26

Thalidomide and Cyclophosphamide in Treating Children With Recurrent or Refractory Childhood Cancers

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
Other solid neoplasm

Unspecified Childhood Solid Tumor, Protocol Specific

Data powered by HemOnc (CC BY 4.0) Colophon âš¡